LLY

1,000.71

-0.48%↓

JNJ

244.74

-0.77%↓

ABBV

235.52

+0.85%↑

NVS

164.63

+0.55%↑

AZN

202.28

+0.84%↑

LLY

1,000.71

-0.48%↓

JNJ

244.74

-0.77%↓

ABBV

235.52

+0.85%↑

NVS

164.63

+0.55%↑

AZN

202.28

+0.84%↑

LLY

1,000.71

-0.48%↓

JNJ

244.74

-0.77%↓

ABBV

235.52

+0.85%↑

NVS

164.63

+0.55%↑

AZN

202.28

+0.84%↑

LLY

1,000.71

-0.48%↓

JNJ

244.74

-0.77%↓

ABBV

235.52

+0.85%↑

NVS

164.63

+0.55%↑

AZN

202.28

+0.84%↑

LLY

1,000.71

-0.48%↓

JNJ

244.74

-0.77%↓

ABBV

235.52

+0.85%↑

NVS

164.63

+0.55%↑

AZN

202.28

+0.84%↑

Home・Akciju saraksts・NeoGenomics Inc

NeoGenomics Inc

Atvērts

9.24 -4.25

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

9.19

Max

9.75

Galvenie mērījumi
By Trading Economics
Ienākumi	17M -9.9M
Pārdošana	2.4M 190M
Peļņas marža	-5.196
Darbinieki	2,500
EBITDA	15M 5.3M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+51.58% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 28. apr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-178M 1.3B
Iepriekšējā atvēršanas cena	13.49
Iepriekšējā slēgšanas cena	9.24

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

7.7 / 10.27 Atbalsts un pretestība

NeoGenomics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 3. marts 13:30 UTC

Galvenie tirgus virzītāji

Crypto Companies Shares Slide As Mideast Conflict Widens

2026. g. 3. marts 03:42 UTC

Galvenie ziņu notikumi

Asian Government Bonds Fall as Middle East Conflict Stokes Inflation Fears -- Update

2026. g. 2. marts 09:54 UTC

Galvenie ziņu notikumi

Oil and Gold Jump, Stocks Slide as Conflict in Middle East Rocks Global Markets

2026. g. 25. febr. 15:07 UTC

Galvenie tirgus virzītāji

GD Culture Shares Rise After Board Authorizes Sale of Bitcoin for Buyback Plan

2026. g. 3. marts 15:01 UTC

Tirgus saruna

Galvenie ziņu notikumi

Bitcoin Could Fall if Middle East Conflict Escalates -- Market Talk

2026. g. 3. marts 08:08 UTC

Tirgus saruna

Galvenie ziņu notikumi

Bitcoin Falls as Prospect of Lasting Middle East Conflict Weighs -- Market Talk

2026. g. 2. marts 20:28 UTC

Peļņas

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

2026. g. 2. marts 17:29 UTC

Iegādes, apvienošanās, pārņemšana

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

2026. g. 2. marts 12:53 UTC

Tirgus saruna

Galvenie ziņu notikumi

Bitcoin Rises But Recovery Looks Weak Amid Geopolitical Uncertainty -- Market Talk

2026. g. 2. marts 08:28 UTC

Tirgus saruna

Galvenie ziņu notikumi

Bitcoin Recovers as Inflation Worries Grow Due to Conflict in Iran -- Market Talk

2026. g. 2. marts 08:27 UTC

Galvenie ziņu notikumi

Bitcoin, Ethereum, XRP Fall. Curious Crypto Trading Amid Conflict in Middle East. -- Barrons.com

2026. g. 2. marts 03:04 UTC

Tirgus saruna

Galvenie ziņu notikumi

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 2. marts 03:04 UTC

Tirgus saruna

Galvenie ziņu notikumi

Bitcoin Rises as Middle East Tensions Test Risk Sentiment -- Market Talk

2026. g. 2. marts 01:21 UTC

Tirgus saruna

Galvenie ziņu notikumi

Crypto Expected to Be Volatile, Weaker Amid Risk-Off Tone -- Market Talk

2026. g. 27. febr. 18:45 UTC

Tirgus saruna

Bitcoin Stays Vulnerable in Choppy Geopolitical Situation -- Market Talk

2026. g. 27. febr. 13:21 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 27. febr. 13:21 UTC

Tirgus saruna

Bitcoin Falls as U.S. Stock Futures Decline -- Market Talk

2026. g. 27. febr. 13:05 UTC

Peļņas

MARA Holdings Stock Surges. The Bitcoin Miner Is Moving Into AI. -- Barrons.com

2026. g. 27. febr. 08:02 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 27. febr. 08:02 UTC

Tirgus saruna

Bitcoin Continues to Struggle For Meaningful Recovery -- Market Talk

2026. g. 26. febr. 13:56 UTC

Tirgus saruna

Bitcoin Falls on Profit-Taking After Earlier Recovery -- Market Talk

2026. g. 26. febr. 09:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 26. febr. 08:21 UTC

Tirgus saruna

Bitcoin Drops as U.S. Stock Futures Fall -- Market Talk

2026. g. 25. febr. 15:45 UTC

Iegādes, apvienošanās, pārņemšana

Coinbase Launches Stock Trading as It Races Robinhood to Be the 'Everything' App -- Barrons.com

2026. g. 25. febr. 15:04 UTC

Tirgus saruna

Cryptocurrencies Rise on Improved Sentiment in U.S. Stocks -- Market Talk

2026. g. 25. febr. 07:58 UTC

Tirgus saruna

Bitcoin Leads Cryptocurrencies Higher as Risk Appetite Recovers -- Market Talk

2026. g. 24. febr. 14:26 UTC

Tirgus saruna

Potential Growth in Stablecoins Could Boost Demand For Treasury Bills -- Market Talk

2026. g. 24. febr. 12:02 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 24. febr. 12:02 UTC

Tirgus saruna

Cryptocurrencies Fall as AI Fears, Tariff Uncertainty Hit Risk Sentiment -- Market Talk

2026. g. 24. febr. 09:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

NeoGenomics Inc Prognoze

Cenas mērķis

By TipRanks

51.58% augšup

Prognoze 12 mēnešiem

Vidējais 14.4 USD 51.58%

Augstākais 16 USD

Zemākais 13 USD

Pamatojoties uz 9 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

9 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 9 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

7.7 / 10.27Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bearish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.